The clinical value of the decfion of percentage of pulmonary perfusion defect scores for pulmonary embolism / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
; (12): 21-22, 2013.
Article
en Zh
| WPRIM
| ID: wpr-431844
Biblioteca responsable:
WPRO
ABSTRACT
Objective To investigate the clinical value of the decfion of percentage of pulmonary perfusion defect score (PPDS%) in patients with pulmonary embolism (PE).Methods A retrospective study was carried out on PPDs% data of patients(n =36) with clinical confirmed PE.The patients were divided into three levels:low (PPDS% <30%),medial (30% ≤PPDS% <50%) and high (PPDS% ≥50%) risk groups,according to the standard of PPDs% diagnosis.the PPDS% and the incidence rate of the clinical adverse events were compared in mild,moderate and severe risk PE.The therapeutic results were compared with the PPDS% changes.Results The mild,moderate and severe risk patients with PE were 15 cases,13 cases and 8 cases respectively,according to the standard of PPDS% diagnosis.16 cases,12 cases and 8 cases respectively,according to the standard of 2008 ESC APE diagnosis and treatment guidelines.The uniform rate was 94.4% for two methods,the uniform rate was 100.0% in which high risk of PE.The PPDS% of PE was (46.2 ± 4.6) % before treatment.The data was significantly higher than that post treatment (31.6% ± 1.8%) (t =17.38,P < 0.01).The scores of low,medial and high risk patients were (25.9 ± 3.9) %,(45.6 ± 4.3) % and (58.4 ± 4.9) % (t =6.18,P < 0.01),respectively.The mild,moderate and severe risk PE according to the PPDS% standard with clinical adverse events for were 1 cases (6.5%),3 cases (23.0%) and 5 cases (62.5 %) respectively,with a significant difference (x2 =8.71,P < 0.05).Conclusion PPDS% could be used as an important reference index for risk stratification of diagnosis,evaluating therapeutic efficiency and predicting the prognosis in patients with PE.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
Zh
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Año:
2013
Tipo del documento:
Article